13F Pro quality score
Rank #2,433 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from Pulmatrix, Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2024 | 10-K/A | $7.8M | $-9.6M | -125.1% |
| FY 2023 | 10-K | $7.3M | $-14.1M | — |
| FY 2022 | 10-K | $6.1M | $-18.8M | — |
| FY 2021 | 10-K | $5.2M | $-20.2M | — |
| FY 2020 | 10-K | $12.6M | $-19.3M | -78.1% |
| FY 2019 | 10-K | $7.9M | $-20.6M | — |
Pulmatrix, Inc. (PULM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PULM at 31.4/100 on a composite quality score built from its SEC filings, placing it at rank #2,433 of 2,925 stocks — the bottom half of the AI-ranked universe. Top institutional holders of PULM by reported 13-F value include RENAISSANCE TECHNOLOGIES, BlackRock, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. PULM trades on the Nasdaq exchange and files with the SEC under CIK 1574235. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PULM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Pulmatrix, Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1574235 →